Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Transplantation. 2021 Aug 11;106(5):950–962. doi: 10.1097/TP.0000000000003920

Figure 5. Proliferating xenoreactive T cells upregulate CD2 expression.

Figure 5.

Figure 5.

(a) PBMCs were analyzed for mean fluorescence intensity (MFI) of CD2 expression following PEC stimulation. Histogram of representative samples (left) shows CD2 MFI on proliferating CD4+ and CD8+ cells (black) when compared with resting (light gray) and nonproliferating (dark gray) cells. The MFI of CD2 on proliferating CD4+ but not CD8+ cells from all tested individuals (right) is significantly higher than resting and nonproliferating cells. (b) Purified naïve and memory cells in the presence or absence of autologous CD14+ monocytes were assessed for MFI of CD2 expression following stimulation with PEC monolayers. (c) CD4+ and CD8+ cells were segregated into four subsets based on surface CD2 and CD28 expression (left). CD4+ proliferating cells show significantly higher levels of CD2hiCD28+ subpopulation when compared with resting and nonproliferating cells. The proliferating CD8+ cells are predominantly CD2hiCD28 and CD2hiCD28+ subsets. (d) Proliferating cells in PEC-stimulated naive and memory cells in the presence or absence of autologous CD14+ monocytes showed increasing frequency of CD2hiCD28+ cells. (* p<0.05, ** p<0.001, *** p<0.0001, ****p<0.00001)